Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 57

1.

Triarylamine-based hydrido-carboxylate rhenium(i) complexes as photosensitizers for dye-sensitized solar cells.

Veronese L, Quartapelle Procopio E, Moehl T, Panigati M, Nonomura K, Hagfeldt A.

Phys Chem Chem Phys. 2019 Apr 3;21(14):7534-7543. doi: 10.1039/c9cp00856j.

PMID:
30896002
2.

Poor prognosis of chromosome 7 clonal aberrations in Philadelphia-negative metaphases and relevance of potential underlying myelodysplastic features in chronic myeloid leukemia.

Bidet A, Dulucq S, Smol T, Marceau-Renaut A, Morisset S, Coiteux V, Noël-Walter MP, Nicolini FE, Tigaud I, Luquet I, Struski S, Gaillard B, Penther D, Tondeur S, Nadal N, Hermet E, Véronèse L, Réa D, Gervais C, Theisen O, Terré C, Cony-Makhoul P, Lefebvre C, Gaillard JB, Radford I, Vervaeke AL, Barin C, Chapiro E, Nguyen-Khac F, Etienne G, Preudhomme C, Mahon FX, Roche-Lestienne C; Groupe Francophone de Cytogénétique Hématologique (GFCH) and the French Intergroup of Chronic Myeloid Leukemia (Fi-LMC).

Haematologica. 2019 Jun;104(6):1150-1155. doi: 10.3324/haematol.2018.208801. Epub 2018 Dec 20.

3.

Outcome and impact of post-remission strategy after MIDAM regimen in patients with relapsing or refractory acute myeloid leukemia.

Bahashwan S, Moluçon-Chabrot C, Hermet E, Ravinet A, Douge A, Veronese L, Tchirkov A, Lemal R, Berger MG, Veyrat-Masson R, Tournilhac O, Bay JO, Guièze R.

Am J Hematol. 2019 Jan;94(1):E32-E35. doi: 10.1002/ajh.25332. Epub 2018 Nov 25. No abstract available.

PMID:
30370957
4.

Extrahepatic Portosystemic Shunt via the Coronary Vein in Noncirrhotic Chronic Portal Vein Thrombosis.

Bodini FC, Rossi S, Veronese L, Colombi D, Michieletti E.

J Vasc Interv Radiol. 2018 Sep;29(9):1327-1330. doi: 10.1016/j.jvir.2018.03.010. No abstract available.

PMID:
30146217
5.

"Double-hit" chronic lymphocytic leukemia: An aggressive subgroup with 17p deletion and 8q24 gain.

Chapiro E, Lesty C, Gabillaud C, Durot E, Bouzy S, Armand M, Le Garff-Tavernier M, Bougacha N, Struski S, Bidet A, Laharanne E, Barin C, Veronese L, Prié N, Eclache V, Gaillard B, Michaux L, Lefebvre C, Gaillard JB, Terré C, Penther D, Bastard C, Nadal N, Fert-Ferrer S, Auger N, Godon C, Sutton L, Tournilhac O, Susin SA, Nguyen-Khac F; GroupeFrancophone de Cytogénétique Hématologique(GFCH) and the French Innovative Leukemia Organization (FILO) group.

Am J Hematol. 2018 Mar;93(3):375-382. doi: 10.1002/ajh.24990. Epub 2017 Dec 18.

6.

Contrast ultrasound LI-RADS LR-5 identifies hepatocellular carcinoma in cirrhosis in a multicenter restropective study of 1,006 nodules.

Terzi E, Iavarone M, Pompili M, Veronese L, Cabibbo G, Fraquelli M, Riccardi L, De Bonis L, Sangiovanni A, Leoni S, Zocco MA, Rossi S, Alessi N, Wilson SR, Piscaglia F; CEUS LI-RADS Italy study group collaborators:.

J Hepatol. 2018 Mar;68(3):485-492. doi: 10.1016/j.jhep.2017.11.007. Epub 2017 Nov 11.

PMID:
29133247
7.

TERT promoter status and gene copy number gains: effect on TERT expression and association with prognosis in breast cancer.

Gay-Bellile M, Véronèse L, Combes P, Eymard-Pierre E, Kwiatkowski F, Dauplat MM, Cayre A, Privat M, Abrial C, Bignon YJ, Mouret-Reynier MA, Vago P, Penault-Llorca F, Tchirkov A.

Oncotarget. 2017 Aug 24;8(44):77540-77551. doi: 10.18632/oncotarget.20560. eCollection 2017 Sep 29.

8.

Lactation performance of Holstein cows treated with 2 formulations of recombinant bovine somatotropin in a large commercial dairy herd in Brazil.

de Morais JPG, da S Cruz AP, Minami NS, Veronese LP, Del Valle TA, Aramini J.

J Dairy Sci. 2017 Jul;100(7):5945-5956. doi: 10.3168/jds.2016-11965. Epub 2017 Apr 27.

9.

ERCC1 and telomere status in breast tumours treated with neoadjuvant chemotherapy and their association with patient prognosis.

Gay-Bellile M, Romero P, Cayre A, Véronèse L, Privat M, Singh S, Combes P, Kwiatkowski F, Abrial C, Bignon YJ, Vago P, Penault-Llorca F, Tchirkov A.

J Pathol Clin Res. 2016 Jul 13;2(4):234-246. eCollection 2016 Oct.

10.

Telomere status in chronic lymphocytic leukemia with TP53 disruption.

Guièze R, Pages M, Véronèse L, Combes P, Lemal R, Gay-Bellile M, Chauvet M, Callanan M, Kwiatkowski F, Pereira B, Vago P, Bay JO, Tournilhac O, Tchirkov A.

Oncotarget. 2016 Aug 30;7(35):56976-56985. doi: 10.18632/oncotarget.10927.

11.

Presence of multiple recurrent mutations confers poor trial outcome of relapsed/refractory CLL.

Guièze R, Robbe P, Clifford R, de Guibert S, Pereira B, Timbs A, Dilhuydy MS, Cabes M, Ysebaert L, Burns A, Nguyen-Khac F, Davi F, Véronèse L, Combes P, Le Garff-Tavernier M, Leblond V, Merle-Béral H, Alsolami R, Hamblin A, Mason J, Pettitt A, Hillmen P, Taylor J, Knight SJ, Tournilhac O, Schuh A.

Blood. 2015 Oct 29;126(18):2110-7. doi: 10.1182/blood-2015-05-647578. Epub 2015 Aug 27.

12.

Forefoot varus predicts subtalar hyperpronation in young people.

Silva RS, Ferreira AL, Veronese LM, Serrão FV.

J Am Podiatr Med Assoc. 2014 Nov;104(6):594-600. doi: 10.7547/8750-7315-104.6.594.

PMID:
25514271
13.

De novo 2q36.1q36.3 interstitial deletion involving the PAX3 and EPHA4 genes in a fetus with spina bifida and cleft palate.

Goumy C, Gay-Bellile M, Eymard-Pierre E, Kemeny S, Gouas L, Déchelotte P, Gallot D, Véronèse L, Tchirkov A, Pebrel-Richard C, Vago P.

Birth Defects Res A Clin Mol Teratol. 2014 Jun;100(6):507-11. doi: 10.1002/bdra.23246. Epub 2014 Apr 18.

PMID:
24753315
14.

14q deletions are associated with trisomy 12, NOTCH1 mutations and unmutated IGHV genes in chronic lymphocytic leukemia and small lymphocytic lymphoma.

Cosson A, Chapiro E, Belhouachi N, Cung HA, Keren B, Damm F, Algrin C, Lefebvre C, Fert-Ferrer S, Luquet I, Gachard N, Mugneret F, Terre C, Collonge-Rame MA, Michaux L, Rafdord-Weiss I, Talmant P, Veronese L, Nadal N, Struski S, Barin C, Helias C, Lafage M, Lippert E, Auger N, Eclache V, Roos-Weil D, Leblond V, Settegrana C, Maloum K, Davi F, Merle-Beral H, Lesty C, Nguyen-Khac F; Groupe Francophone de Cytogénétique Hématologique.

Genes Chromosomes Cancer. 2014 Aug;53(8):657-66. doi: 10.1002/gcc.22176. Epub 2014 Apr 12.

PMID:
24729385
15.

Radiofrequency ablation of pancreatic neuroendocrine tumors: a pilot study of feasibility, efficacy, and safety.

Rossi S, Viera FT, Ghittoni G, Cobianchi L, Rosa LL, Siciliani L, Bortolotto C, Veronese L, Vercelli A, Gallotti A, Ravetta V.

Pancreas. 2014 Aug;43(6):938-45. doi: 10.1097/MPA.0000000000000133.

PMID:
24717825
16.

Vemurafenib in patients with BRAF(V600) mutated metastatic melanoma: an open-label, multicentre, safety study.

Larkin J, Del Vecchio M, Ascierto PA, Krajsova I, Schachter J, Neyns B, Espinosa E, Garbe C, Sileni VC, Gogas H, Miller WH Jr, Mandalà M, Hospers GA, Arance A, Queirolo P, Hauschild A, Brown MP, Mitchell L, Veronese L, Blank CU.

Lancet Oncol. 2014 Apr;15(4):436-44. doi: 10.1016/S1470-2045(14)70051-8. Epub 2014 Feb 27.

PMID:
24582505
17.

Vemurafenib in patients with BRAF(V600) mutation-positive melanoma with symptomatic brain metastases: final results of an open-label pilot study.

Dummer R, Goldinger SM, Turtschi CP, Eggmann NB, Michielin O, Mitchell L, Veronese L, Hilfiker PR, Felderer L, Rinderknecht JD.

Eur J Cancer. 2014 Feb;50(3):611-21. doi: 10.1016/j.ejca.2013.11.002. Epub 2013 Nov 29.

PMID:
24295639
18.

The influence of forefoot varus on eccentric hip torque in adolescents.

Scattone Silva R, Veronese LM, Granado Ferreira AL, Serrão FV.

Man Ther. 2013 Dec;18(6):487-91. doi: 10.1016/j.math.2013.05.001. Epub 2013 Jun 4.

PMID:
23756032
19.

Prenatal ultrasound diagnosis of a 48,XXYY syndrome.

Kemeny S, Pebrel-Richard C, Gouas L, Veronese L, Lemery D, Tchirkov A, Goumy C, Vago P.

Morphologie. 2013 Jun;97(317):65-7. doi: 10.1016/j.morpho.2013.01.001. Epub 2013 Mar 7.

PMID:
23473874
20.

Radiofrequency ablation of metastatic lesions from breast cancer.

Bortolotto C, Macchi S, Veronese L, Dore R, Draghi F, Rossi S.

J Ultrasound. 2012 Sep;15(3):199-205. doi: 10.1016/j.jus.2012.06.007. Epub 2012 Jun 27.

21.

Patterns of appearance and risk of misdiagnosis of intrahepatic cholangiocarcinoma in cirrhosis at contrast enhanced ultrasound.

Galassi M, Iavarone M, Rossi S, Bota S, Vavassori S, Rosa L, Leoni S, Venerandi L, Marinelli S, Sangiovanni A, Veronese L, Fraquelli M, Granito A, Golfieri R, Colombo M, Bolondi L, Piscaglia F.

Liver Int. 2013 May;33(5):771-9. doi: 10.1111/liv.12124. Epub 2013 Feb 27.

PMID:
23445369
22.

Contribution of MLPA to routine diagnostic testing of recurrent genomic aberrations in chronic lymphocytic leukemia.

Véronèse L, Tournilhac O, Combes P, Prie N, Pierre-Eymard E, Guièze R, Veyrat-Masson R, Bay JO, Vago P, Tchirkov A.

Cancer Genet. 2013 Jan-Feb;206(1-2):19-25. doi: 10.1016/j.cancergen.2012.12.002. Epub 2013 Jan 10.

PMID:
23313109
23.

Chromosomal aberrations and their prognostic value in a series of 174 untreated patients with Waldenström's macroglobulinemia.

Nguyen-Khac F, Lambert J, Chapiro E, Grelier A, Mould S, Barin C, Daudignon A, Gachard N, Struski S, Henry C, Penther D, Mossafa H, Andrieux J, Eclache V, Bilhou-Nabera C, Luquet I, Terre C, Baranger L, Mugneret F, Chiesa J, Mozziconacci MJ, Callet-Bauchu E, Veronese L, Blons H, Owen R, Lejeune J, Chevret S, Merle-Beral H, Leblondon V; Groupe Français d'Etude de la Leucémie Lymphoïde Chronique et Maladie de Waldenström (GFCLL/MW); Groupe Ouest-Est d’étude des Leucémie Aiguës et Autres Maladies du Sang (GOELAMS); Groupe d’Etude des Lymphomes de l’Adulte (GELA).

Haematologica. 2013 Apr;98(4):649-54. doi: 10.3324/haematol.2012.070458. Epub 2012 Oct 12.

24.

Telomeres and chromosomal instability in chronic lymphocytic leukemia.

Véronèse L, Tournilhac O, Callanan M, Prie N, Kwiatkowski F, Combes P, Chauvet M, Davi F, Gouas L, Verrelle P, Guièze R, Vago P, Bay JO, Tchirkov A.

Leukemia. 2013 Feb;27(2):490-3. doi: 10.1038/leu.2012.194. Epub 2012 Jul 13. No abstract available.

PMID:
22878603
25.

[Physiopathological, diagnostic and therapeutic impacts of chromosomal translocations in hematological malignancies].

Ravinet A, Gay Belille M, Lemal R, Veronese L, Bay JO, Prie N.

Bull Cancer. 2011 Dec;98(12):1403-18. doi: 10.1684/bdc.2011.1509. Review. French.

26.

Molecular phenotypes of matched in situ and invasive components of breast carcinomas.

Martins D, Sousa B, Lopes N, Gomes M, Veronese L, Albergaria A, Paredes J, Schmitt F.

Hum Pathol. 2011 Oct;42(10):1438-46. doi: 10.1016/j.humpath.2010.08.024. Epub 2011 Mar 29.

PMID:
21450330
27.

De novo unbalanced translocation 2;4 characterized by metaphase CGH and array CGH in a child with mental retardation and dysmorphic features.

Debost-Legrand A, Capri Y, Gouas L, Pebrel-Richard C, Veronese L, Tchirkov A, Haoud K, Boespflug-Tanguy O, Goumy C, Vago P.

Pathol Biol (Paris). 2011 Dec;59(6):309-13. doi: 10.1016/j.patbio.2010.11.004. Epub 2010 Dec 9.

PMID:
21145667
28.

Alterations in Vitamin D signalling and metabolic pathways in breast cancer progression: a study of VDR, CYP27B1 and CYP24A1 expression in benign and malignant breast lesions.

Lopes N, Sousa B, Martins D, Gomes M, Vieira D, Veronese LA, Milanezi F, Paredes J, Costa JL, Schmitt F.

BMC Cancer. 2010 Sep 11;10:483. doi: 10.1186/1471-2407-10-483.

29.

P-cadherin, vimentin and CK14 for identification of basal-like phenotype in breast carcinomas: an immunohistochemical study.

Sousa B, Paredes J, Milanezi F, Lopes N, Martins D, Dufloth R, Vieira D, Albergaria A, Veronese L, Carneiro V, Carvalho S, Costa JL, Zeferino L, Schmitt F.

Histol Histopathol. 2010 Aug;25(8):963-74. doi: 10.14670/HH-25.963.

PMID:
20552547
30.

Increased expression of the oncogenic KLF6-SV1 transcript in human glioblastoma.

Tchirkov A, Sapin V, Marceau G, Chautard E, Narla G, Veronese L, Friedman S, Khalil T, Vago P, Kemeny JL, Verrelle P.

Clin Chem Lab Med. 2010 Aug;48(8):1167-70. doi: 10.1515/CCLM.2010.219.

PMID:
20545576
31.

Retinoid pathway and congenital diaphragmatic hernia: hypothesis from the analysis of chromosomal abnormalities.

Goumy C, Gouas L, Marceau G, Coste K, Veronese L, Gallot D, Sapin V, Vago P, Tchirkov A.

Fetal Diagn Ther. 2010;28(3):129-39. doi: 10.1159/000313331. Epub 2010 May 26. Review.

32.

Cryptococcosis parotid diagnosed by FNAC in a non-immunosuppressed patient.

Bernabé DG, Veronese LA, Miyahara GI, Biasoli ER, Moraes NP.

Cytopathology. 2010 Oct;21(5):343-5. doi: 10.1111/j.1365-2303.2010.00760.x. Epub 2010 Apr 26. No abstract available.

PMID:
20482716
33.

Prenatal detection of cryptic rearrangements by multiplex ligation probe amplification in fetuses with ultrasound abnormalities.

Goumy C, Gouas L, Pebrel-Richard C, Véronèse L, Eymard-Pierre E, Debost-Legrand A, Haoud K, Tchirkov A, Vago P.

Genet Med. 2010 Jun;12(6):376-80. doi: 10.1097/GIM.0b013e3181e074c6.

PMID:
20453657
34.

A thrombocytosis occurring in Philadelphia positive CML in molecular response to imatinib can reveal an underlying JAK2(V617F) myeloproliferative neoplasm.

Véronèse L, Tchirkov A, Richard-Pebrel C, Ledoux-Pilon A, Fleury J, Chaleteix C, Goumy C, Gouas L, Berger MG, Vago P, Bay JO, Tournilhac O.

Leuk Res. 2010 Apr;34(4):e94-6. doi: 10.1016/j.leukres.2009.09.025. Epub 2009 Oct 14. No abstract available.

PMID:
19833389
35.

Strong correlation between VEGF and MCL-1 mRNA expression levels in B-cell chronic lymphocytic leukemia.

Véronèse L, Tournilhac O, Verrelle P, Davi F, Dighiero G, Chautard E, Veyrat-Masson R, Kwiatkowski F, Goumy C, Gouas L, Bay JO, Vago P, Tchirkov A.

Leuk Res. 2009 Dec;33(12):1623-6. doi: 10.1016/j.leukres.2009.05.003. Epub 2009 May 31.

PMID:
19487028
36.

Gain of the short arm of chromosome 2 (2p) is a frequent recurring chromosome aberration in untreated chronic lymphocytic leukemia (CLL) at advanced stages.

Chapiro E, Leporrier N, Radford-Weiss I, Bastard C, Mossafa H, Leroux D, Tigaud I, De Braekeleer M, Terré C, Brizard F, Callet-Bauchu E, Struski S, Veronese L, Fert-Ferrer S, Taviaux S, Lesty C, Davi F, Merle-Béral H, Bernard OA, Sutton L, Raynaud SD, Nguyen-Khac F.

Leuk Res. 2010 Jan;34(1):63-8. doi: 10.1016/j.leukres.2009.03.042. Epub 2009 Apr 29.

PMID:
19406473
37.

Detection of HPV in mouth floor squamous cell carcinoma and its correlation with clinicopathologic variables, risk factors and survival.

Simonato LE, Garcia JF, Sundefeld ML, Mattar NJ, Veronese LA, Miyahara GI.

J Oral Pathol Med. 2008 Nov;37(10):593-8. doi: 10.1111/j.1600-0714.2008.00704.x.

PMID:
19012621
38.

Familial deletion 11q14.3-q22.1 without apparent phenotypic consequences: a haplosufficient 8.5 Mb region.

Goumy C, Gouas L, Tchirkov A, Roucaute T, Giollant M, Veronèse L, Francannet C, Vago P.

Am J Med Genet A. 2008 Oct 15;146A(20):2668-72. doi: 10.1002/ajmg.a.32511.

PMID:
18798310
39.

[Prognosis of chronic lymphocytic leukemia: focus on recent biomarkers].

Véronèse L, Tchirkov A, Gouas L, Périssel B, Goumy C, Vago P.

Ann Biol Clin (Paris). 2008 Jul-Aug;66(4):371-7. doi: 10.1684/abc.2008.0246. Review. French.

40.

Gene dosage methods as diagnostic tools for the identification of chromosome abnormalities.

Gouas L, Goumy C, Véronèse L, Tchirkov A, Vago P.

Pathol Biol (Paris). 2008 Sep;56(6):345-53. doi: 10.1016/j.patbio.2008.03.010. Epub 2008 Jun 2. Review.

PMID:
18513889
41.

Gingival metastasis from salivary duct carcinoma of the parotid gland.

Bernabé DG, Veronese LA, Miyahara GI, Conrado-Neto S, Biasoli ER.

J Periodontol. 2008 Apr;79(4):748-52. doi: 10.1902/jop.2008.070283 .

PMID:
18380570
42.

Larsen-like phenotype associated with partial trisomy 3p and monosomy 5p.

Goumy C, Beaufrère AM, Tchirkov A, Gouas L, Gaspard F, Giollant M, Roucaute T, Veronèse L, Lemery D, Vago P.

Prenat Diagn. 2008 Feb;28(2):131-4. doi: 10.1002/pd.1928.

PMID:
18236428
43.

Low MCL-1 mRNA expression correlates with prolonged survival in B-cell chronic lymphocytic leukemia.

Véronèse L, Tournilhac O, Verrelle P, Davi F, Dighiero G, Chautard E, Veyrat-Masson R, Kwiatkowski F, Goumy C, Vago P, Travade P, Tchirkov A.

Leukemia. 2008 Jun;22(6):1291-3. Epub 2007 Nov 29. No abstract available.

PMID:
18046444
44.

Interleukin-6 gene amplification and shortened survival in glioblastoma patients.

Tchirkov A, Khalil T, Chautard E, Mokhtari K, Véronèse L, Irthum B, Vago P, Kémény JL, Verrelle P.

Br J Cancer. 2007 Feb 12;96(3):474-6. Epub 2007 Jan 16.

45.

Antiretroviral activity of pegylated interferon alfa-2a in patients co-infected with HIV/hepatitis C virus.

Aguilar Marucco D, Veronese L, de Requena DG, Bonora S, Calcagno A, Cavecchia I, Sinicco A, De Rosa FG, Cariti G, Di Perri G.

J Antimicrob Chemother. 2007 Mar;59(3):565-8. Epub 2007 Jan 9.

PMID:
17213263
46.

The early HCV RNA dynamics in patients with acute hepatitis C treated with pegylated interferon-alpha2b.

De Rosa FG, Bargiacchi O, Audagnotto S, Garazzino S, Cariti G, Veronese L, Raiteri R, Calleri G, Di Perri G.

Antivir Ther. 2006;11(2):165-71.

PMID:
16640097
47.

Resolution of HCV infection after highly active antiretroviral therapy in a HIV-HCV coinfected patient.

De Rosa FG, Audagnotto S, Bargiacchi O, Garazzino S, Aguilar Marucco D, Veronese L, Canta F, Bonora S, Sinicco A, Di Perri G.

J Infect. 2006 Nov;53(5):e215-8. Epub 2006 Mar 20.

PMID:
16549201
48.

Treatment of acute C hepatitis in HIV-infected patients.

Audagnotto S, De Rosa FG, Bargiacchi O, Garazzino S, Veronese L, Cariti G, Di Perri G.

J Acquir Immune Defic Syndr. 2005 Sep 1;40(1):110-1. No abstract available.

PMID:
16123692
49.

Is a 3-month course of treatment with Peg-interferon effective in acute HCV hepatitis?

Cariti G, Quaglia S, Meoli I, Veronese L, Audagnotto S, De Blasi T, Mancardi E, Raiteri R, Di Perri G.

J Biol Regul Homeost Agents. 2003 Apr-Jun;17(2):188-90.

PMID:
14518721
50.

The effects of lamotrigine on the pharmacokinetics of lithium.

Chen C, Veronese L, Yin Y.

Br J Clin Pharmacol. 2000 Sep;50(3):193-5.

Supplemental Content

Loading ...
Support Center